{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:25:27Z","timestamp":1773285927756,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11899-017-0361-6","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T07:31:58Z","timestamp":1487748718000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Studies in Hematologic Microtransplantation"],"prefix":"10.1007","volume":"12","author":[{"given":"Kevin A.","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Strair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"issue":"5","key":"361_CR1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3324\/haematol.2015.132860","volume":"101","author":"R Storb","year":"2016","unstructured":"Storb R, Sandmaier BM. Nonmyeloablative allogeneic hematopoietic cell transplantation. Haematologica. 2016;101(5):521\u201330.","journal-title":"Haematologica"},{"key":"361_CR2","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Guo M, Hu KX, Liu GX, Yu CL, Qiao JH, Sun QY, et al. HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up. J Clin Oncol Offic J Am Soc Clin Oncol. 2012;30(33):4084\u201390. This is an important clinical study that demonstrates microtransplantation and induction of host and donor T cells that target an AML-associated epitope.","DOI":"10.1200\/JCO.2012.42.0281"},{"key":"361_CR3","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Guo M, Hu KX, Yu CL, Sun QY, Qiao JH, Wang DH, et al. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood. 2011;117(3):936\u201341. This is a key microtransplant study. It demonstrates the feasibility of administering a uniform regimen to patients with AML with little\/no toxicity and good anti-tumor effect.","DOI":"10.1182\/blood-2010-06-288506"},{"issue":"4","key":"361_CR4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5966\/sctm.2015-0196","volume":"5","author":"KX Hu","year":"2016","unstructured":"Hu KX, Sun QY, Guo M, Qiao JX, Yu CL, Qiao JH, et al. A study of human leukocyte antigen mismatched cellular therapy (stem cell microtransplantation) in high-risk myelodysplastic syndrome or transformed acute myelogenous leukemia. Stem Cell Trans Med. 2016;5(4):524\u20139.","journal-title":"Stem Cell Trans Med"},{"issue":"91","key":"361_CR5","first-page":"15","volume":"17","author":"K Mantripragada","year":"2014","unstructured":"Mantripragada K, Reagan JL, Quesenberry PJ, Fast LD. Advances in cellular therapy for the treatment of leukemia. Discov Med. 2014;17(91):15\u201324.","journal-title":"Discov Med"},{"key":"361_CR6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1479-5876-11-150","volume":"11","author":"JL Reagan","year":"2013","unstructured":"Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, et al. Cellular immunotherapy for refractory hematological malignancies. J Transl Med. 2013;11:150.","journal-title":"J Transl Med"},{"key":"361_CR7","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Spitzer TR. Microtransplantation: a new paradigm for the separation of graft versus host disease and graft versus tumor? J Clin Oncol Offic J Am Soc Clin Oncol. 2012;30(33):4051\u20132. This editorial places microtransplantation in the context of earlier pre-clinical and clinical studies.","DOI":"10.1200\/JCO.2012.45.2979"},{"key":"361_CR8","doi-asserted-by":"crossref","unstructured":"Mohrbacher, A. et al. Microtransplantation: HLA-mismatched allogeneic cellular therapy of acute myeloid leukemia. Blood. 2014;124(21):5944.","DOI":"10.1182\/blood.V124.21.5944.5944"},{"issue":"4","key":"361_CR9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bjh.12771","volume":"165","author":"R Fores","year":"2014","unstructured":"Fores R, Dorado N, Vilches C, Regidor C, Garcia-Marco JA, de Pablo R, et al. HLA-partially matched cellular therapy (stem-cell microtransplantation) for acute myeloid leukaemia: description of four cases. Br J Haematol. 2014;165(4):580\u20131.","journal-title":"Br J Haematol"},{"issue":"4","key":"361_CR10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199908270-00006","volume":"68","author":"TR Spitzer","year":"1999","unstructured":"Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. CD2Transplant. 1999;68(4):480\u20134.","journal-title":"CD2Transplant"},{"issue":"2","key":"361_CR11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood.V100.2.442","volume":"100","author":"KK Ballen","year":"2002","unstructured":"Ballen KK, Becker PS, Emmons RV, Fitzgerald TJ, Hsieh CC, Liu Q, et al. Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy. Blood. 2002;100(2):442\u201350.","journal-title":"Blood"},{"issue":"12","key":"361_CR12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.exphem.2005.06.032","volume":"33","author":"KK Ballen","year":"2005","unstructured":"Ballen KK, Colvin G, Dey BR, Porter D, Westervelt P, Spitzer TR, et al. Cellular immune therapy for refractory cancers: novel therapeutic strategies. Exp Hematol. 2005;33(12):1427\u201335.","journal-title":"Exp Hematol"},{"issue":"4","key":"361_CR13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.1999.17.4.1234","volume":"17","author":"DL Porter","year":"1999","unstructured":"Porter DL, Connors JM, Van Deerlin VM, Duffy KM, McGarigle C, Saidman SL, et al. Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies. J Clin Oncol Offic J Am Soc Clin Oncol. 1999;17(4):1234.","journal-title":"J Clin Oncol Offic J Am Soc Clin Oncol"},{"issue":"4","key":"361_CR14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/bbmt.2001.v7.pm11349810","volume":"7","author":"DL Porter","year":"2001","unstructured":"Porter DL, Luger SM, Duffy KM, Stadtmauer EA, Laport G, Schuster SJ, et al. Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2001;7(4):230\u20138.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"361_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60683-5","volume":"15","author":"DH Katz","year":"1972","unstructured":"Katz DH, Benacerraf B. The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol. 1972;15:1\u201394.","journal-title":"Adv Immunol"},{"issue":"2","key":"361_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.133.2.169","volume":"133","author":"DH Katz","year":"1971","unstructured":"Katz DH, Paul WE, Goidl EA, Benacerraf B. Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med. 1971;133(2):169\u201386.","journal-title":"J Exp Med"},{"issue":"1","key":"361_CR17","first-page":"133","volume":"32","author":"DH Katz","year":"1972","unstructured":"Katz DH, Ellman L, Paul WE, Green I, Benacerraf B. Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells. Cancer Res. 1972;32(1):133\u201340.","journal-title":"Cancer Res"},{"issue":"1","key":"361_CR18","first-page":"141","volume":"32","author":"L Ellman","year":"1972","unstructured":"Ellman L, Katz DH, Green I, Paul WE, Benacerraf B. Mechanisms involved in the antileukemic effect of immunocompetent allogeneic lymphoid cell transfer. Cancer Res. 1972;32(1):141\u20138.","journal-title":"Cancer Res"},{"issue":"6","key":"361_CR19","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2002-12-3949","volume":"102","author":"MT Rubio","year":"2003","unstructured":"Rubio MT, Kim YM, Sachs T, Mapara M, Zhao G, Sykes M. Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma. Blood. 2003;102(6):2300\u20137.","journal-title":"Blood"},{"issue":"2","key":"361_CR20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4049\/jimmunol.175.2.665","volume":"175","author":"MT Rubio","year":"2005","unstructured":"Rubio MT, Saito TI, Kattleman K, Zhao G, Buchli J, Sykes M. Mechanisms of the antitumor responses and host-versus-graft reactions induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: a critical role for recipient CD4+ T cells and recipient leukocyte infusion-derived IFN-gamma-producing CD8+ T cells. J Immunol (Baltimore, Md: 1950). 2005;175(2):665\u201376.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"1","key":"361_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2006.03.004","volume":"120","author":"MT Rubio","year":"2006","unstructured":"Rubio MT, Zhao G, Buchli J, Chittenden M, Sykes M. Role of indirect allo- and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions (RLI) in mixed chimeras prepared with nonmyeloablative conditioning. Clin Immunol (Orlando, Fla). 2006;120(1):33\u201344.","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"361_CR22","doi-asserted-by":"crossref","unstructured":"\u2022 Dey BR, McAfee S, Colby C, Cieply K, Caron M, Saidman S, et al. Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol. 2005;128(3):351\u20139. This older clinical analysis is highlighted because many of the clinical findings described emphasize important issues relating to current concepts of microtransplantation.","DOI":"10.1111\/j.1365-2141.2004.05328.x"},{"issue":"5","key":"361_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbmt.2008.02.013","volume":"14","author":"HJ Symons","year":"2008","unstructured":"Symons HJ, Levy MY, Wang J, Zhou X, Zhou G, Cohen SE, et al. The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2008;14(5):499\u2013509.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"11","key":"361_CR24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/bbmt.2001.v7.pm11760148","volume":"7","author":"BR Dey","year":"2001","unstructured":"Dey BR, McAfee S, Sackstein R, Colby C, Saidman S, Weymouth D, et al. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2001;7(11):604\u201312.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"3A","key":"361_CR25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1083-8791(00)70056-5","volume":"6","author":"TR Spitzer","year":"2000","unstructured":"Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P, et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2000;6(3A):309\u201320.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"5","key":"361_CR26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1083-8791(03)00077-6","volume":"9","author":"BR Dey","year":"2003","unstructured":"Dey BR, McAfee S, Colby C, Sackstein R, Saidman S, Tarbell N, et al. Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2003;9(5):320\u20139.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"10","key":"361_CR27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00007890-200211270-00011","volume":"74","author":"LH Buhler","year":"2002","unstructured":"Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation. 2002;74(10):1405\u20139.","journal-title":"Transplantation"},{"issue":"9","key":"361_CR28","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1600-6143.2006.01434.x","volume":"6","author":"Y Fudaba","year":"2006","unstructured":"Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant Offic J Am Soc Transplant Am Soc Transplant Surg. 2006;6(9):2121\u201333.","journal-title":"Am J Transplant Offic J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"4","key":"361_CR29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","volume":"358","author":"T Kawai","year":"2008","unstructured":"Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358(4):353\u201361.","journal-title":"N Engl J Med"},{"issue":"6","key":"361_CR30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/TP.0b013e31820a3068","volume":"91","author":"TR Spitzer","year":"2011","unstructured":"Spitzer TR, Sykes M, Tolkoff-Rubin N, Kawai T, McAfee SL, Dey BR, et al. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation. 2011;91(6):672\u20136.","journal-title":"Transplantation"},{"issue":"4","key":"361_CR31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbmt.2008.12.503","volume":"15","author":"GA Colvin","year":"2009","unstructured":"Colvin GA, Berz D, Ramanathan M, Winer ES, Fast L, Elfenbein GJ, et al. Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2009;15(4):421\u201331.","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"361_CR32","doi-asserted-by":"crossref","unstructured":"Reagan JL, Fast LD, Nevola M, Mantripragada K, Mulder A, Claas FH, et al. Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia. Blood Canc J. 2015;5:e371.","DOI":"10.1038\/bcj.2015.100"},{"issue":"20","key":"361_CR33","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1200\/JCO.2003.05.094","volume":"21","author":"RK Strair","year":"2003","unstructured":"Strair RK, Schaar D, Medina D, Todd MB, Aisner J, DiPaola RS, et al. Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinoma. J Clin Oncol Offic J Am Soc Clin Oncol. 2003;21(20):3785\u201391.","journal-title":"J Clin Oncol Offic J Am Soc Clin Oncol"},{"issue":"12","key":"361_CR34","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.leukres.2008.05.015","volume":"32","author":"DJ Medina","year":"2008","unstructured":"Medina DJ, Gharibo M, Savage P, Cohler A, Kuriyan M, Balsara B, et al. A pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies. Leuk Res. 2008;32(12):1842\u20138.","journal-title":"Leuk Res"},{"issue":"2","key":"361_CR35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12032-009-9250-8","volume":"27","author":"Q Chen","year":"2010","unstructured":"Chen Q, Lin RB, Ye YB, Fan NF, Guo ZQ, Zhou ZF, et al. The combined administration of partially HLA-matched irradiated allogeneic lymphocytes and thalidomide in advanced renal-cell carcinoma: a case report. Med Oncol (Northwood, London, England). 2010;27(2):554\u20138.","journal-title":"Med Oncol (Northwood, London, England)"},{"issue":"5","key":"361_CR36","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.3892\/ol.2015.2995","volume":"9","author":"X Kong","year":"2015","unstructured":"Kong X, Chen Y, Wang LI, Zhou Y, He Y, Nie W, et al. Effect of the microtransplantation of allogeneic hematopoietic stem cells as maintenance therapy for elderly patients with acute leukemia. Oncol Lett. 2015;9(5):2331\u20134.","journal-title":"Oncol Lett"},{"issue":"26","key":"361_CR37","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1182\/blood-2009-02-202598","volume":"113","author":"U Keilholz","year":"2009","unstructured":"Keilholz U, Letsch A, Busse A, Asemissen AM, Bauer S, Blau IW, et al. A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS. Blood. 2009;113(26):6541\u20138.","journal-title":"Blood"},{"issue":"3","key":"361_CR38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.beha.2008.07.004","volume":"21","author":"K Rezvani","year":"2008","unstructured":"Rezvani K, Barrett AJ. Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation. Best Pract Res Clin Haematol. 2008;21(3):437\u201353.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"24 Pt 1","key":"361_CR39","doi-asserted-by":"crossref","first-page":"8799","DOI":"10.1158\/1078-0432.CCR-05-1314","volume":"11","author":"K Rezvani","year":"2005","unstructured":"Rezvani K, Brenchley JM, Price DA, Kilical Y, Gostick E, Sewell AK, et al. T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms\u2019 tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization. Clin Canc Res Offic J Am Assoc Canc Res. 2005;11(24 Pt 1):8799\u2013807.","journal-title":"Clin Canc Res Offic J Am Assoc Canc Res"},{"issue":"6","key":"361_CR40","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2002-01-0163","volume":"100","author":"C Scheibenbogen","year":"2002","unstructured":"Scheibenbogen C, Letsch A, Thiel E, Schmittel A, Mailaender V, Baerwolf S, et al. CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood. 2002;100(6):2132\u20137.","journal-title":"Blood"},{"issue":"2","key":"361_CR41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MOH.0000000000000116","volume":"22","author":"N Kekre","year":"2015","unstructured":"Kekre N, Koreth J. Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes. Curr Opin Hematol. 2015;22(2):116\u201322.","journal-title":"Curr Opin Hematol"},{"key":"361_CR42","doi-asserted-by":"crossref","unstructured":"Mancusi A, Ruggeri L, Velardi A. Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. Blood. 2016;128(23):2616\u20132623.","DOI":"10.1182\/blood-2016-07-730564"},{"key":"361_CR43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2016.00188","volume":"7","author":"P Vacca","year":"2016","unstructured":"Vacca P, Montaldo E, Croxatto D, Moretta F, Bertaina A, Vitale C, et al. NK cells and other innate lymphoid cells in hematopoietic stem cell transplantation. Front Immunol. 2016;7:188.","journal-title":"Front Immunol"},{"issue":"7","key":"361_CR44","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/bmt.2014.74","volume":"49","author":"YS Chen","year":"2014","unstructured":"Chen YS, Kong XJ, Zhang XH, Yin XL. Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation. Bone Marrow Transplant. 2014;49(7):984\u20135.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"361_CR45","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","volume":"375","author":"F Milano","year":"2016","unstructured":"Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, et al. Cord-blood transplantation in patients with minimal residual disease. N Engl J Med. 2016;375(10):944\u201353.","journal-title":"N Engl J Med"},{"issue":"7","key":"361_CR46","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/bmt.2011.195","volume":"47","author":"TL Kindwall-Keller","year":"2012","unstructured":"Kindwall-Keller TL, Hegerfeldt Y, Meyerson HJ, Margevicius S, Fu P, van Heeckeren W, et al. Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies. Bone Marrow Transplant. 2012;47(7):924\u201333.","journal-title":"Bone Marrow Transplant"},{"issue":"19","key":"361_CR47","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-220525","volume":"114","author":"MR Verneris","year":"2009","unstructured":"Verneris MR, Brunstein CG, Barker J, MacMillan ML, DeFor T, McKenna DH, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood. 2009;114(19):4293\u20139.","journal-title":"Blood"},{"issue":"18","key":"361_CR48","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","volume":"371","author":"JE Wagner Jr","year":"2014","unstructured":"Wagner Jr JE, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, et al. One-unit versus two-unit cord-blood transplantation for hematologic cancers. N Engl J Med. 2014;371(18):1685\u201394.","journal-title":"N Engl J Med"},{"issue":"26","key":"361_CR49","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2016-01-694349","volume":"127","author":"G Michel","year":"2016","unstructured":"Michel G, Galambrun C, Sirvent A, Pochon C, Bruno B, Jubert C, et al. Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome. Blood. 2016;127(26):3450\u20137.","journal-title":"Blood"},{"issue":"5","key":"361_CR50","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3324\/haematol.2015.138594","volume":"101","author":"K Besien van","year":"2016","unstructured":"van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, et al. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival. Haematologica. 2016;101(5):634\u201343.","journal-title":"Haematologica"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-017-0361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-017-0361-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-017-0361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T21:00:53Z","timestamp":1601672453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-017-0361-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s11899-017-0361-6","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}